This virtual public workshop provided a venue for stakeholders to examine bottlenecks to innovation in drug research and development (R&D) for prevalent chronic diseases and to highlight opportunities ...

The goal of this collaborative is to examine and highlight the bottlenecks to drug research and development (R&D) for highly prevalent chronic diseases and develop a set of key considerations and ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

From groundbreaking treatments for chronic and infectious diseases and innovative therapies targeting previously untreatable conditions to advances in personalized and precision medicine, the pursuit ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

As Artificial Intelligence (AI) becomes more popular in everyday life, drug research and development companies are incorporating it into their process. Dotmatics, an early research and development ...

A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...

Prescription drugs account for 15 percent of health care costs. Yet they’re our best defense against the chronic diseases that drive 90 percent of health care spending. That’s why policymakers ought ...